Rhizen Is Swiss Hq Biotech Focused On Discovery And Development Of Innovativesmall Molecule Drugs For The Treatment Of Cancer & Inflammatory Diseaseswe Have Demonstrated Our Leadership Of The Pi3K Space Through Our Discovery Of Umbralisib & Tenalisib Class Leading Pi3K Isoform Specific Inhibitors That Are Poised To Transform The Nhl & Cll Space We Have A Deep Pipeline Of Novel Differentiated Assets Across Various Stages Of Development
No conferences found for this company.
| Company Name | Rhizen Pharmaceuticals Sa |
| Country |
Switzerland
|
| Address | N/A |
| Telephone | N/A |
| N/A |
Enter your address and we will specify the offer for your area.